Skip to content
healthcare.dev

Itovebi

NDC 50242-079, Inavolisib, tablet, film coated, from Genentech, Inc..

Product NDC
50242-079
Status
Listed
Labeler
Genentech, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219249
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INAVOLISIB9 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Phosphoinositide 3-Kinase alpha Inhibitors [MoA]

Package NDCNDC-11Package
50242-079-08502420079081 BOTTLE in 1 CARTON (50242-079-08) / 28 TABLET, FILM COATED in 1 BOTTLE
50242-079-86502420079861 BOTTLE in 1 CARTON (50242-079-86) / 28 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5de59f5b-e5db-410f-b692-658686ef4107

Use it

Look up 50242-079 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-079. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.